Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Portfolio Review of Hereditary Blood Disorders, 6501 [E6-1677]
Download as PDF
<![CDATA[
6501
Federal Register / Vol. 71, No. 26 / Wednesday, February 8, 2006 / Notices
ESTIMATE OF ANNUALIZED BURDEN TABLE
Number of
respondents
Type of data collection
PACE EH Requestor Survey .......................................................................................................
PACE EH Participant Interviews .................................................................................................
Dated: February 1, 2006.
Betsey Dunaway,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E6–1695 Filed 2–7–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
and the Agency for Toxic Substances
and Disease Registry.
Dated: February 2, 2006.
Diane Allen,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E6–1689 Filed 2–7–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Advisory Committee to the Director,
Centers for Disease Control and
Prevention; Meeting
rmajette on PROD1PC67 with NOTICES1
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following Advisory
Committee meeting.
Name: Advisory Committee to the
Director (ACD), CDC.
Time and Date: 8:30 a.m.–4:30 p.m.,
February 23, 2006.
Place: CDC, Global Communications
Center (Building 19), 1600 Clifton Road,
Atlanta, Georgia 30333.
Status: Open to the public, limited
only by the space available. The meeting
room accommodates approximately 75
people.
Purpose: The committee will provide
advice to the CDC Director on strategic
and other broad issues facing CDC.
Matters To Be Discussed: Agenda
items will include updates on CDC
priorities with discussions of program
activities including updates on CDC
scientific and programmatic activities,
strategic imperatives, goals, research
agenda, and health equity.
Agenda items are subject to change as
priorities dictate.
For Further Information Contact:
Lynn Austin, PhD., Executive Secretary,
Advisory Committee to the Director,
CDC, 1600 Clifton Road, NE., M/S D–14,
Atlanta, Georgia 30333. Telephone 404/
639–7000.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Portfolio
Review of Hereditary Blood Disorders
VerDate Aug<31>2005
19:41 Feb 07, 2006
Jkt 208001
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting:
Name: Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Portfolio Review
of Hereditary Blood Disorders.
Times and Dates: 9:30 a.m.–5 p.m.,
March 2, 2006 (Closed). 9 a.m.–4 p.m.,
March 3, 2006 (Closed).
Place: National Center on Birth
Defects and Developmental Disabilities,
CDC, 12 Executive Park Drive, Atlanta,
GA 30329, Telephone Number
404.498.3800.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in section 552b(c)(4)
and (6), Title 5 U.S.C., and the
Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters To Be Discussed: The meeting
will include the review and discussion
of the Hereditary Blood Disorders
Division’s strategies and activities.
For Further Information Contact:
Esther Sumartojo, Acting Associate
Director for Science and Public Health,
National Center on Birth Defects and
Developmental Disabilities, CDC, 1600
Clifton Road, NE., Mailstop E–87,
Atlanta, GA 30333, Telephone Number
404.498.3800.
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden per response
(in hours)
1
1
45/60
1
872
192
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: February 2, 2006.
Diane Allen,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E6–1677 Filed 2–7–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Center for Environmental
Health/Agency for Toxic Substances
and Disease Registry
The Community and Tribal
Subcommittee (CTS) of the Board of
Scientific Counselors (BSC), Centers for
Disease Control and Prevention (CDC),
National Center for Environmental
Health/Agency for Toxic Substances
and Disease Registry (NCEH/ATSDR):
Teleconference.
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), CDC, NCEH/ATSDR
announces the following subcommittee
meeting:
Name: Community and Tribal
Subcommittee (CTS).
Time and Date: 1 p.m.–2:30 p.m.,
February 27, 2006.
Place: The teleconference will
originate at NCEH/ATSDR in Atlanta,
Georgia. Please see Supplementary
Information for details on accessing the
teleconference.
Status: Open to the public,
teleconference access limited only by
availability of telephone ports.
Purpose: Under the charge of the BSC,
NCEH/ATSDR the CTS will provide the
board with a forum for community and
tribal first-hand perspectives on the
interactions and impacts of the NCEH/
E:\FR\FM\08FEN1.SGM
08FEN1
]]>Agencies
[Federal Register Volume 71, Number 26 (Wednesday, February 8, 2006)]
[Notices]
[Page 6501]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-1677]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Portfolio Review of Hereditary Blood Disorders
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting:
Name: Disease, Disability, and Injury Prevention and Control
Special Emphasis Panel (SEP): Portfolio Review of Hereditary Blood
Disorders.
Times and Dates: 9:30 a.m.-5 p.m., March 2, 2006 (Closed). 9 a.m.-4
p.m., March 3, 2006 (Closed).
Place: National Center on Birth Defects and Developmental
Disabilities, CDC, 12 Executive Park Drive, Atlanta, GA 30329,
Telephone Number 404.498.3800.
Status: The meeting will be closed to the public in accordance with
provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director, Management Analysis and Services
Office, CDC, pursuant to Public Law 92-463.
Matters To Be Discussed: The meeting will include the review and
discussion of the Hereditary Blood Disorders Division's strategies and
activities.
For Further Information Contact: Esther Sumartojo, Acting Associate
Director for Science and Public Health, National Center on Birth
Defects and Developmental Disabilities, CDC, 1600 Clifton Road, NE.,
Mailstop E-87, Atlanta, GA 30333, Telephone Number 404.498.3800.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: February 2, 2006.
Diane Allen,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. E6-1677 Filed 2-7-06; 8:45 am]
BILLING CODE 4163-18-P
